Firm
After two decades at Kass International, Geetha Kandiah discusses the lessons that shaped her career, building an inclusive regional firm, and AI opportunities
With patent filings stagnant, fewer clients litigating and market consolidation at play, Canadian firms are considering how to challenge the established players
IPH’s strategy of integrating acquired businesses into its larger premium brands, may offer an early signal of how externally funded IP firms will pursue scale, efficiency and market strength
After bringing on board three new partners, the recently merged firm has its eyes on breaking into the top-flight of firms for patent disputes and ITC litigation
Sponsored
Sponsored
-
Sponsored by MaiwaldFive female patent attorneys at Maiwald, spanning several age groups and practice areas, explain how the intellectual property firm encourages the career development of women and talented young professionals -
Sponsored by Bugnion SpAAndrea Cappai of Bugnion SpA considers the strengths and weaknesses of GlobalBlock and GlobalBlock+ as trademark protection tools and draws comparisons with several other options in the quest for a unified solution
-
Sponsored by Tilleke & GibbinsLoc Xuan Le, Duc Anh Tran, and Linh Duy Mai of T&G Law Firm LLC, the local associate firm of Tilleke & Gibbins in Vietnam, report on the country’s first criminal trial involving copyright and related rights infringement
-
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen and Chi Lan Dang of Tilleke & Gibbins say regulations concerning the new Inspection and Appeal Department and a 2023 circular are steps towards improved handling of intellectual property appeals
-
Sponsored by Remfry & SagarAarti Aggarwal of Remfry & Sagar reports that a decision concerning a company licensed to use the Nokia brand name has confirmed that generic concepts or ideas cannot be protected through copyright
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Suvarna Pandey of RNA, Technology and IP Attorneys consider the implications of a High Court of Delhi ruling concerning a patented compound used to treat non-small cell lung cancer
